These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19233048)

  • 21. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?
    Emery P
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():87-90. PubMed ID: 8535655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis.
    Sutor SM; Gricar JA; Cave DG
    Manag Care Interface; 1999 Jun; 12(6):51-3. PubMed ID: 10538460
    [No Abstract]   [Full Text] [Related]  

  • 24. Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years.
    Sany J; Cohen JD; Combescure C; Bozonnat MC; Roch-Bras F; Lafon G; Daurès JP
    Rheumatology (Oxford); 2009 Oct; 48(10):1236-41. PubMed ID: 19620209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness analysis of drug therapies for rheumatoid arthritis.
    Criswell LA; Such CL
    J Rheumatol Suppl; 1996 Mar; 44():52-5. PubMed ID: 8833053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
    Lundkvist J; Kastäng F; Kobelt G
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of pharmaco-economic considerations on the utilization of novel anti-rheumatic therapies.
    Lipsky PE; Kavanaugh A
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():41-4. PubMed ID: 10646490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case study on rheumatoid arthritis.
    Baker T
    Am J Manag Care; 2003 Sep; 9(4 Suppl):S87-98. PubMed ID: 14527109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
    Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Symptomatic therapy of rheumatic diseases. How they reduce pain and thereby safe costs].
    Bolten WW
    MMW Fortschr Med; 2002 Aug; 144(33-34):30-6. PubMed ID: 12380141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists].
    Kulp W; Greiner W; Graf von der Schulenburg JM
    Pharm Unserer Zeit; 2003; 32(5):420-5. PubMed ID: 14526463
    [No Abstract]   [Full Text] [Related]  

  • 34. Early inflammatory arthritis versus rheumatoid arthritis.
    Finckh A
    Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early rheumatoid arthritis.
    Machold KP; Nell V; Stamm T; Aletaha D; Smolen JS
    Curr Opin Rheumatol; 2006 May; 18(3):282-8. PubMed ID: 16582693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of rheumatoid arthritis. Based on a presentation by Frederick Wolfe, MD.
    Am J Manag Care; 1999 Sep; 5(14 Suppl):S852-9; discussion S866-9. PubMed ID: 10621071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential for altering rheumatoid arthritis outcome.
    Quinn MA; Emery P
    Rheum Dis Clin North Am; 2005 Nov; 31(4):763-72. PubMed ID: 16287596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of rheumatoid arthritis and access to treatment: a medical overview.
    Smolen J; Aletaha D
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S39-47. PubMed ID: 18157733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.
    Lindgren P; Geborek P; Kobelt G
    Int J Technol Assess Health Care; 2009 Apr; 25(2):181-9. PubMed ID: 19331709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early treatment in early undifferentiated arthritis.
    Olivieri I; Sarzi-Puttini P; Bugatti S; Atzeni F; d'Angelo S; Caporali R
    Autoimmun Rev; 2012 Jun; 11(8):589-92. PubMed ID: 22037115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.